Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
ABOS	Acumen Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$121.33M	n/a	-172.3%	n/a	-$2.00
ABPO	Abpro Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$2.89M	n/a	n/a	n/a	-$1.30
ACOG	Alpha Cognition Inc. Manufacturing · Year ended 2025-12-31 · USD	$10.22M	-$20.67M	-202.2%	-33.1%	n/a	-$1.18
ADMA	ADMA Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$510.17M	$146.93M	28.8%	30.8%	19.6%	$0.60
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
AGEN	Agenus Inc Manufacturing · Year ended 2025-12-31 · USD	$114.20M	-$3.08M	-2.7%	n/a	10.4%	$0.00
AGTX	Agentix Corp. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$485.6K	n/a	n/a	n/a	-$0.01
AIM	AIM ImmunoTech Inc. Manufacturing · Year ended 2025-12-31 · USD	$88.0K	-$13.96M	n/m	n/a	-48.2%	-$8.62
ALEC	Alector, Inc. Manufacturing · Year ended 2025-12-31 · USD	$21.05M	-$142.93M	-679.2%	-466.3%	-79.1%	-$1.39
ALGS	Aligos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.19M	-$24.19M	n/m	-45.2%	-39.5%	-$2.45
ALLO	Allogene Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$190.89M	n/a	-65.3%	-100.0%	-$0.87
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
APTN	Adaptin Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$5.17M	n/a	n/a	n/a	-$0.66
ARMP	Armata Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$173.80M	n/a	n/a	n/a	-$4.80
ARTV	Artiva Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$83.86M	n/a	-76.3%	-100.0%	-$3.43
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57
ATYR	aTYR PHARMA INC Manufacturing · Year ended 2025-12-31 · USD	$190.0K	-$74.12M	n/m	-109.8%	-19.1%	-$0.80
AURA	Aura Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$106.19M	n/a	-77.6%	n/a	-$1.76
AUTL	Autolus Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$75.39M	-$287.53M	-381.4%	-161.4%	644.9%	-$1.08
AVXL	Anavex Life Sciences Corp. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$46.38M	n/a	-48.9%	n/a	-$0.54
BCAB	BioAtla, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.61M	n/a	-164.7%	n/a	-$1.01
BCDA	BioCardia, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$8.23M	n/a	-919.3%	-100.0%	n/a
BCLI	Brainstorm Cell Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.31M	n/a	n/a	n/a	-$1.11
BCRX	BioCryst Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$874.84M	$263.86M	30.2%	n/a	94.1%	$1.21
BDTX	Black Diamond Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.00M	$22.37M	32.0%	19.9%	n/a	$0.39
BEAM	Beam Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$139.74M	-$79.99M	-57.2%	-6.5%	120.0%	-$0.81
BIIB	Biogen Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.89B	$1.29B	13.1%	7.1%	2.2%	$8.79
BKHA	Black Hawk Acquisition Corp Manufacturing · Year ended 2025-11-30 · USD	n/a	$1.33M	n/a	n/a	n/a	n/a
CABA	Cabaletta Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.86M	n/a	-149.8%	n/a	-$2.10
CADL	Candel Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$38.18M	n/a	-73.5%	n/a	-$0.72
CCCC	C4 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.95M	-$104.99M	-292.1%	-40.9%	1.0%	-$1.27
CELZ	Creative Medical Technology Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$6.0K	-$6.00M	n/m	-79.8%	-45.5%	-$2.52
CERO	Cero Therapeutics Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.92M	n/a	n/a	n/a	n/a
CGEM	Cullinan Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$219.88M	n/a	-53.8%	n/a	n/a
CGEN	Compugen Ltd Manufacturing · Year ended 2025-12-31 · USD	$72.76M	$35.34M	48.6%	34.4%	161.1%	$0.38
CGON	CG Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.04M	-$161.00M	n/m	-21.4%	254.7%	-$2.08
CGTX	Cognition Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.49M	n/a	-68.5%	n/a	-$0.32
CHRS	Coherus Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$168.02M	n/a	275.4%	n/a	$1.43
CLDI	Calidi Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.91M	n/a	-529.6%	n/a	-$5.95
CMPX	Compass Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$66.49M	n/a	-33.8%	-100.0%	n/a
CPMV	Mosaic ImmunoEngineering Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$687.8K	n/a	n/a	n/a	-$0.10
CRBU	Caribou Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.16M	-$148.12M	n/m	-121.2%	11.7%	-$1.59
CRDF	Cardiff Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$593.0K	-$45.85M	n/m	-101.0%	-13.2%	-$0.69
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58
CRSP	CRISPR Therapeutics AG Manufacturing · Year ended 2025-12-31 · USD	$3.51M	-$581.60M	n/m	-30.3%	-90.6%	-$6.47
CSBR	Champions Oncology, Inc. Manufacturing · Year ended 2026-04-30 · USD	$59.42M	-$1.18M	-2.0%	-29.8%	4.4%	-$0.08
CVM	CEL SCI Corp Manufacturing · Year ended 2025-09-30 · USD	n/a	-$25.41M	n/a	-159.2%	n/a	-$6.27
DBVT	DBV Technologies S.A. Manufacturing · Year ended 2025-12-31 · USD	$5.64M	-$146.95M	n/m	-87.1%	35.8%	-$1.05
DNA	Ginkgo Bioworks Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$170.16M	-$312.76M	-183.8%	-61.5%	-25.1%	-$5.64
DNLI	Denali Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$512.54M	n/a	-50.6%	n/a	-$2.97
DTIL	Precision Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$34.26M	-$45.72M	-133.4%	-49.6%	-50.1%	-$3.56
DYAI	Dyadic International Inc Manufacturing · Year ended 2025-12-31 · USD	$3.09M	-$7.36M	-238.3%	-597.6%	-11.6%	-$0.23
EDIT	Editas Medicine, Inc. Manufacturing · Year ended 2025-12-31 · USD	$40.52M	-$160.06M	-395.0%	-586.6%	25.4%	-$1.80
ELOX	Eloxx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$6.00M	n/a	n/a	-100.0%	-$0.49
ELUT	Elutia Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	$53.38M	n/a	192.9%	n/a	$0.87
ENGN	enGene Therapeutics Inc. Manufacturing · Year ended 2025-10-31 · USD	n/a	-$117.30M	n/a	-69.9%	n/a	$2.29
ENTX	Entera Bio Ltd. Manufacturing · Year ended 2025-12-31 · USD	$42.0K	-$11.44M	n/m	-87.3%	-76.8%	$0.25
ESLA	Estrella Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.06M	n/a	n/a	n/a	-$0.35
EXEL	Exelixis, Inc. Manufacturing · Year ended 2026-01-02 · USD	$2.32B	$782.57M	33.7%	36.2%	7.0%	$2.78
EXOZ	Exozymes Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$9.16M	n/a	-269.6%	n/a	-$1.09
FATE	Fate Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	$6.65M	-$136.31M	n/m	-65.8%	-51.2%	-$1.15
FDMT	4D Molecular Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.21M	-$140.11M	-164.4%	-27.7%	n/m	-$2.42
FENC	Fennec Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.64M	-$9.74M	-21.8%	-27.5%	-6.1%	-$0.34
GILD	Gilead Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$29.44B	$8.51B	28.9%	37.6%	2.4%	$6.78
GLUE	Monte Rosa Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$123.67M	-$38.63M	-31.2%	-16.6%	63.5%	n/a
GPLB	Green Planet Bio Engineering Co. Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$35.8K	n/a	n/a	n/a	$0.00
GRML	Greenland Mines Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.55M	n/a	-111.5%	n/a	-$0.22
HALO	Halozyme Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.40B	$316.89M	22.7%	649.2%	37.6%	$2.56
HUMA	Humacyte, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$40.83M	n/m	n/m	n/a	-$0.26
IBRX	ImmunityBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$113.29M	-$351.40M	-310.2%	n/a	668.3%	-$0.38
IKT	Inhibikase Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$48.26M	n/a	-27.9%	n/a	-$0.49
IMA	ImageneBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$800.0K	-$45.35M	n/m	-34.1%	-77.1%	-$9.64
IMCR	Immunocore Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$400.02M	-$35.51M	-8.9%	-9.3%	29.0%	-$0.71
IMVT	Immunovant, Inc. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$505.61M	n/a	-59.3%	n/a	-$2.77
INAB	IN8BIO, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.44M	n/a	-70.5%	n/a	-$4.44
INBX	Inhibrx Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.30M	-$140.06M	n/m	n/m	550.0%	-$9.04
INKT	MiNK Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$12.49M	n/a	n/a	n/a	-$2.93
INMB	Inmune Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$50.0K	-$45.93M	n/m	-195.3%	257.1%	-$1.86
INTS	Intensity Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.61M	n/a	-97.7%	n/a	-$8.56
IOVA	Iovance Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$263.50M	-$390.98M	-148.4%	-56.0%	60.6%	-$1.09
IPSC	Century Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$109.16M	-$9.58M	-8.8%	-6.0%	n/m	-$0.14
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
JSPR	Jasper Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$75.80M	n/a	n/m	n/a	-$3.95
KLRS	Kalaris Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$43.44M	n/a	-55.1%	n/a	-$2.85
KOD	Kodiak Sciences Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$229.97M	n/a	-146.1%	n/a	-$4.32
KRYS	Krystal Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$389.13M	$204.83M	52.6%	16.8%	33.9%	$6.84
KYMR	Kymera Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$39.21M	-$311.35M	-794.0%	-19.7%	-16.7%	-$3.69
KYTX	Kyverna Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$161.31M	n/a	-69.4%	n/a	-$3.64
LCTX	Lineage Cell Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.56M	-$63.53M	-436.5%	-146.6%	53.2%	-$0.28
LENZ	LENZ Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$19.09M	-$82.13M	-430.3%	-28.9%	n/a	-$2.85
LIMN	Liminatus Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.21M	n/a	n/a	n/a	-$0.43
LONA	LeonaBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.61M	n/a	-380.0%	n/a	-$24.70
LXEO	Lexeo Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$99.96M	n/a	-40.5%	n/a	-$1.86
MAZE	Maze Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$131.12M	n/a	-36.9%	n/a	-$3.05
MGTX	MeiraGTx Holdings plc Manufacturing · Year ended 2025-12-31 · USD	$81.39M	-$114.20M	-140.3%	n/a	144.6%	-$1.42
MGX	Metagenomi Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$25.21M	-$87.87M	-348.5%	-55.4%	-51.8%	-$2.36
MRNA	Moderna, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.94B	-$2.82B	-145.2%	-32.6%	-39.9%	-$7.26
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67
NMRA	Neumora Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$236.93M	n/a	-228.1%	n/a	-$1.45
NVAX	Novavax Inc Manufacturing · Year ended 2025-12-31 · USD	$1.12B	$440.30M	39.2%	n/a	64.7%	$2.58

Rows per page: 25 50100